LSTA FY 2012 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+42.6% YoY

Gross Profit

$2M16.6% margin

Operating Income

-$30M-212.0% margin

Net Income

-$55M-382.3% margin

EPS (Diluted)

$-600.00

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$6,712

Balance Sheet

Total Assets

$54M

Total Liabilities

$22M

Stockholders' Equity

$33M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+42.6%
Gross Profit	$2M	$1M	+69.7%
Operating Income	-$30M	-$34M	+10.6%
Net Income	-$55M	-$47M	-16.2%